首页> 外文期刊>British Journal of Obstetrics and Gynaecology >Second trimester maternal serum beta human chorionic gonadotrophin and pregnancy outcome.
【24h】

Second trimester maternal serum beta human chorionic gonadotrophin and pregnancy outcome.

机译:孕中期孕妇血清β人绒毛膜促性腺激素和妊娠结局。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this prospective, controlled study was to examine the relation between second trimester maternal serum beta human chorionic gonadotrophin (HCG) and birthweight. The study population consisted of 192 women with maternal serum betaHCG > or = 3.5 multiple of the median and a control group with the same number of women with maternal serum betaHCG < or = 2.0 multiple of the median. There was no difference in birthweight and other pregnancy outcomes between the two groups. When used prospectively, elevated betaHCG in the mid-trimester is not a predictor for intrauterine growth restriction or other pregnancy complications.
机译:这项前瞻性,对照研究的目的是检查孕中期孕妇血清β人绒毛膜促性腺激素(HCG)与出生体重之间的关系。研究人群包括192名孕妇的孕妇血清betaHCG>等于中位数的3.5倍和对照组,以及相同数量的孕妇的孕妇血清betaHCG <中位数= 2.0倍的妇女。两组的出生体重和其他妊娠结局无差异。当前瞻性地使用时,孕中期的βHCG升高并不是子宫内生长受限或其他妊娠并发症的预兆。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号